Answers are grounded in this paper and cite their sources.
The gene expression signatures were relatively stable within patients over time. BAFF and interferon gene expression were markers of patients with generally higher disease activity, but changes in these gene signatures did not coincide with changes in disease activity. Plasma Cell gene signature expression tracked with the traditional SLE serologic markers of anti-dsDNA and complement.
No takes yet. Share an insight, caveat, or question.
Petri et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: